Now FDA Approved.
Robin Miskel didn’t start her Sanofi US career working in the company’s Rare Diseases group, but after supporting her mother through a life-threatening diagnosis, she was inspired to work more closely with patients. Today, Robin is enjoying her new position as a Care Coordination Case Manager Specialist for Sanofi Genzyme’s US Rare Diseases.
Sanofi US continues its efforts to complete the return and reimbursement process associated with the October 28, 2015, voluntary nationwide product recall of Auvi-Q® (epinephrine injection, USP).
Last update: March 30, 2017